PMV Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Commercial Services » Miscellaneous Commercial Services
ETSYEtsy, Inc. -5.44%108.227.5%$440.55m
EFXEquifax, Inc. -1.54%209.512.0%$138.90m
CRLCharles River Laboratories International, Inc. -0.32%219.454.4%$127.25m
CPRTCopart, Inc. -1.66%128.234.4%$116.49m
FLTFLEETCOR Technologies, Inc. -0.46%235.224.0%$113.68m
BAHBooz Allen Hamilton Holding Corp. -0.33%98.722.1%$85.95m
MEDPMedpace Holdings, Inc. -1.41%171.981.1%$58.47m
TAXLiberty Tax, Inc. Class A -0.38%36.972.5%$50.40m
EVOPEVO Payments, Inc. -0.06%33.450.0%$50.14m
SYNHSyneos Health, Inc. -0.90%66.400.0%$47.37m
GETYGetty Images Holdings, Inc. -4.72%30.500.0%$46.79m
FOURShift4 Payments, Inc. -4.31%45.810.0%$46.43m
FCNFTI Consulting, Inc. -0.08%168.715.8%$46.20m
PAGSPagSeguro Digital Ltd. -10.87%12.790.0%$44.89m
EVHEvolent Health, Inc. -0.37%34.8710.1%$41.40m

Company Profile

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in Cranbury, NY.